Soothing Scents Blog

Kaiser Permanente, Oakland, California AUTHORS: Sarah Todd, BSN, RN, Lisa Haas, BSN, RN, Dean McCann, Data Consultant, Perioperative Services DATE: October 2019 FINDINGS: In a trial conducted by Kaiser Permanente Fontana Medical Center results revealed 67% of patients did not require additional antiemetics after administering QueaseEASE in the PACU setting and 100% of the trial participants stated they found QueaseEASE

Providence St. Patrick Hospital, Missoula, Montana AUTHOR: Michelle Leiby and Katie Trottier, Providence St. Patrick Hospital DATE: TBA FINDINGS: In an investigational trial involving 65 patients at Providence St. Patrick Hospital, the need for additional antiemetics decreased by 71.8% when QueaseEASE was used as a first-line nausea treatment in PACU. READ THE FULL STUDY, AVAILABLE AS PART OF OUR RESEARCH

Doernbecher Children’s Hospital, Portland, Oregon AUTHORS: Sonya McBryde, BSN, RN, CPEN, CEN; Denise Langley, MBA, BSN, RN; Melinda Hartenstein, BSN, RN, CEN, CPEN  DATE: September 2017 FINDINGS: A study conducted in a Level 1 Trauma Center Pediatric Emergency Department showed that 79% of patients’ nausea was reduced or eliminated after using QueaseEASE®. READ THE FULL STUDY, AVAILABLE AS PART OF